Last updated 2026-07-26
- Acquired by bioMérieux for $38M, Jan 2026
- Raised $9.5M Series D led by bioMrieux,, May 2020
- Raised $7M Series B led by Axcel Partners, May 2014
Total raised
$18.1M
Last: Undisclosed Round 2020-06
Stage
Series D
Founded
2007
Headcount
70
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
About
Accellix developed a compact flow cytometry platform that delivers rapid, accurate, and automated cell phenotyping results for quality control in cell and gene therapy manufacturing and blood characterization. The platform automates the entire QC workflow from sample preparation to data analysis, aiming to simplify and standardize cellular analysis. Accellix was acquired by bioMérieux in January 2026 for approximately $38 million.
Funding history · 7 rounds · $18.1M total
2020-05
D Round
$9.5M
★ bioMrieux,
2014-05
B Round
$7.0M
★ Axcel Partners
2012-03
A Round Extension
$1.6M
2010-07
A Round Extension
Undisclosed
2010-05
Debt Financing
Undisclosed
2009-08
A Round
Undisclosed
2009-06
Seed
Undisclosed
Headcount over time
From 22 (2019-03) to 70 (2026-07) · +48 (+218%) · 52 points · source: Finder history + radar grounding
Q&A
- What is Accellix's primary business?
- Accellix provides a rapid, easy-to-use, automated cell phenotyping platform for quality control in cell and gene therapy manufacturing and blood characterization.
- When was Accellix acquired and by whom?
- Accellix was acquired by bioMérieux in January 2026 for approximately $38 million.
- What was Accellix's most recent funding round?
- Accellix raised a D Round of $10,000,000 in December 2021, with BroadOak Capital Partners as a lead investor.
- How many employees does Accellix currently have?
- Accellix has 51–200 employees.
- What was a significant funding event for Accellix in 2020?
- In June 2020, Accellix raised a $9.5 million Series D round with lead investors bioMérieux and existing major investors.
- Did Accellix secure any debt financing recently?
- In April 2020, Accellix secured $8.5 million in convertible debt financing from existing major investors.
- What was a key product development announced by Accellix in 2020?
- In April 2020, Accellix announced its next-generation Accellix Instrument and Consumable, designed to further simplify and automate the QC workflow in cell therapy manufacturing.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Technologies
Platforms & InterfacesSoftware
Target customers
ConsumersDemographics & FamilyBabiesHealthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 Patents
Tags
medical-technologieshospitalsreal-timemedical-deviceslaboratoriescritical-careblood-testbiomarkersdiagnosticsoperating-roomsdata-analyticssoftware-developmentdoctorsimmunotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | accellix.com |
|---|---|
| linkedin.com/company/19221336 | |
| facebook.com/Accellix-by-LeukoDx-1630405383882153 | |
| YouTube | youtube.com/channel/UCViMRT-DKhzvqevPlWZnxHQ |
Identifiers & details
| Legal name | Accellix, Inc. |
|---|---|
| Former names | LeukoDx |
| Founded | 2007 |
| Employees (exact) | 70 |
| Offices | San Jose |
Acquisitions & public offerings
Acquired by bioMérieux 2026-01 $38.0M
Radar intelligence
Patents
| EPO | 5 |
|---|
Web history (Wayback)
| Domain | accellix.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514248251 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2009-03-02 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 3 — people (2), charge (1) |
| Registered address | הלוי שלמה (מומו) 5 ירושלים |
Recent registry events
| Date | Event |
|---|---|
| 2025-07-25 | עדכון דירקטורים-הסרת דירקטור |
| 2025-07-25 | עדכון דירקטורים-הוספת דירקטור |
| 2026-01-15 | סילוק שעבוד |